Tao-Hong-Si-Wu-Tang protects against methionine- and choline-deficient diet-induced hepatic steatosis in rats and is associated with inhibition of oxidative stress, inflammation, apoptosis, and pyroptosis - Summary - MDSpire

Tao-Hong-Si-Wu-Tang protects against methionine- and choline-deficient diet-induced hepatic steatosis in rats and is associated with inhibition of oxidative stress, inflammation, apoptosis, and pyroptosis

  • By

  • Luyao Xu

  • Qiuling Li

  • Chengqin Lu

  • Mincheng Zheng

  • Wenhai Guo

  • Yun Chen

  • Jiaying Dai

  • Yao Deng

  • Ning Zhang

  • Kanlin Yang

  • Xinling Chen

  • Kangrong Wang

  • Guohang Yan

  • Hantao Li

  • Rui Duan

  • Jiean Xu

  • Wei Liu

  • Hongzhi Yang

  • Jinwen Xu

  • Min Dai

  • Yaxing Zhang

  • July 6, 2026

  • 0 min

Share

Objective:

To investigate the therapeutic effect of Tao-Hong-Si-Wu-Tang (THSWT) on hepatic steatosis induced by a methionine- and choline-deficient (MCD) diet in rats and its underlying mechanisms.

Approach:
  • Study Design: Rats were divided into control, model, and treatment groups receiving varying doses of THSWT after being fed an MCD diet for two weeks.
  • Evaluation Methods: Hepatic steatosis was assessed using H&E staining, Oil Red O staining, and qPCR for lipid metabolism-related genes, along with immunoblotting for key proteins.
Key Findings:
  • THSWT (2.5 g/kg/day) significantly alleviated hepatic steatosis and slight fibrosis in MCD diet-fed rats.
  • THSWT treatment reduced levels of hepatic reactive oxygen species (ROS), 3-nitrotyrosine (3-NT), and malondialdehyde (MDA), while increasing hepatic GSH levels.
  • THSWT inhibited TLR4/9-IKK-NF-κB-TNF-α/IL-1β/IL-18 innate immune signaling and apoptosis signaling pathways.
Interpretation:

THSWT may alleviate hepatic steatosis through mechanisms involving the reduction of oxidative stress, inflammation, apoptosis, and pyroptosis.

Limitations:
  • The study was conducted on a small sample size of rats (n = 3-4 for dose exploration and n = 7 for confirmation).
  • Further studies are needed to confirm the effects in larger populations and different models.
Conclusion:

THSWT shows potential as a therapeutic agent for hepatic steatosis, warranting further exploration in clinical settings.

Original Source(s)

Related Content